Diederik van der Reijt, Founder, Board of Directors and Chief Executive Officer

It has been an absolute pleasure working with Dr. Aaron Uri Levy.

Aaron joined NKore late last year to lead the company through its next stage of growth, and from day one he has exceeded every expectation. He has done an exceptional job safeguarding and advancing the groundbreaking technology developed over more than 35 years by the late Professor Anahid Jewett at UCLA, ensuring her scientific legacy continues with the highest level of integrity and purpose.

Under Aaron's leadership, NKore has achieved several major milestones in a remarkably short period of time. He successfully led the submission of our FDA Pre-IND package, stabilized and significantly scaled our clinical operations in Cancun, where we are now actively treating patients with various forms of Stage IV cancer, and built a world-class team around the company.

Aaron is an outstanding communicator—transparent, thoughtful, and highly collaborative. He has also had the courage to make difficult decisions when necessary, always with the long-term success of the company and, most importantly, the patients in mind. Those decisions have strengthened NKore and positioned it for the next phase of growth.

Thank you, Aaron, for your dedication, leadership, and unwavering commitment to our mission. I truly enjoy working with you and look forward to seeing NKore achieve its vision of bringing transformative, non-toxic cancer therapies to patients around the world who need them most.

The future of cancer treatment is incredibly exciting, and I believe Aaron will play an important role in helping make that future a reality.

All my best,

Diederik (Didi) van der Reijt